Relationship between serum butyrylcholinesterase and the metabolic syndrome

被引:90
作者
Randell, EW
Mathews, MS
Zhang, HW
Seraj, JS
Sun, G
机构
[1] HCCSJ, Div Lab Med, St John, NF A1B 3V6, Canada
[2] Mem Univ Newfoundland, Fac Med, Div Lab Med, St John, NF A1B 3V6, Canada
[3] Mem Univ Newfoundland, Fac Med, Div Genet, St John, NF A1B 3V6, Canada
[4] Mem Univ Newfoundland, Fac Med, Div Community Hlth, St John, NF A1B 3V6, Canada
关键词
obesity; metabolic syndrome; butyrylcholinesterase; cholinesterase; hyperlipidemia; insulin resistance; diabetes;
D O I
10.1016/j.clinbiochem.2005.04.008
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Objective: To identify independent predictors of serum butyrylcholinesterase (BuChE) activity and examine its relationship with the metabolic syndrome. Design and methods: Serum BuChE activity was measured and metabolic syndrome risk factors were assessed in 1097 healthy subjects recruited from the Newfoundland adult population. Results: Serum BuChE activity was related to insulin homeostasis and correlated with fasting insulin levels (r = 0.266, P < 0.001) and insulin resistance (HOMA-R) index (r = 0.292, P < 0.001) and was higher in individuals with risk factors for the metabolic syndrome. BuChE activity was higher in males than in females and correlated most strongly with serum triglyceride levels (r = 0.363, P < 0.001) and indicators of abdominal obesity (r = 0.355, P < 0.001). Percent trunk fat (beta = 0.185, P < 0.001), triglyceride levels (beta = 0.225, P < 0.001), sex (beta = -0.202, P = 0.001), glucose (beta = 0.209, P < 0.001), insulin (beta = 0.360, P = 0.011), HOMA-R (beta = -0.319, P = 0.044), and age (beta = 0.086, P = 0.002) were independent predictors of BuChE activity. Conclusions: These results suggest the involvement of BuChE in the pathophysiological process constituting the metabolic syndrome. Whether increased BuChE activity precedes or follows the development of risk factors is not known. (c) 2005 The Canadian Society of Clinical Chemists. All rights reserved.
引用
收藏
页码:799 / 805
页数:7
相关论文
共 28 条
[1]   The variable expression of the C4/5 complex of human butyrylcholinesterase and body mass index [J].
Alcântara, VM ;
Rodrigues, LC ;
Oliveira, LC ;
Chautard-Freire-Maia, EA .
HUMAN BIOLOGY, 2003, 75 (01) :47-55
[2]   Butyrylcholinesterase activity and risk factors for coronary artery disease [J].
Alcântara, VM ;
Chautard-Freire-Maia, EA ;
Scartezini, M ;
Cerci, MSJ ;
Braun-Prado, K ;
Picheth, G .
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2002, 62 (05) :399-404
[3]   RELATIONSHIP BETWEEN SERUM PSEUDOCHOLINESTERASE AND TRIGLYCERIDES IN EXPERIMENTALLY INDUCED DIABETES-MELLITUS IN RATS [J].
ANNAPURNA, V ;
SENCIALL, I ;
DAVIS, AJ ;
KUTTY, KM .
DIABETOLOGIA, 1991, 34 (05) :320-324
[4]   Diet, obesity, and cardiovascular risk [J].
Bonow, RO ;
Eckel, RH .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (21) :2057-2058
[5]   CHOLINESTERASE IN SERUM AND LOW-DENSITY LIPOPROTEIN OF HYPERLIPIDEMIC PATIENTS [J].
CHU, MI ;
FONTAINE, P ;
KUTTY, KM ;
MURPHY, D ;
REDHEENDRAN, R .
CLINICA CHIMICA ACTA, 1978, 85 (01) :55-59
[6]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497
[7]   Serum γ-glutamyltransferase and/or serum cholinesterase as markers of the metabolic syndrome [J].
Cucuianu, M .
DIABETES CARE, 1999, 22 (08) :1381-1382
[8]   Ghrelin degradation by serum and tissue homogenates: Identification of the cleavage sites [J].
De Vriese, C ;
Gregoire, F ;
Lema-Kisoka, R ;
Waelbroeck, M ;
Robberecht, P ;
Delporte, C .
ENDOCRINOLOGY, 2004, 145 (11) :4997-5005
[9]   Butyrylcholinesterase K variant on chromosome 31 is associated with Type 11 diabetes white Caucashm subjects [J].
Hashim, Y ;
Shepherd, D ;
Wiltshire, S ;
Holman, RR ;
Levy, JC ;
Clark, A ;
Cull, CA .
DIABETOLOGIA, 2001, 44 (12) :2227-2230
[10]   The metabolic syndrome: Pathophysiology, clinical relevance, and use of niacin [J].
Ito, MK .
ANNALS OF PHARMACOTHERAPY, 2004, 38 (02) :277-285